Improving Rare Disease Clinical Trial Design
Clincierge CEO Scott Gray recently spoke to PM360 about strategies to improve rare disease clinical trial design.
PM360
Menu
Menu
Clincierge CEO Scott Gray recently spoke to PM360 about strategies to improve rare disease clinical trial design.
View the results of our recent research to explore how effective patient support strategies can reduce barriers, increase retention, and improve outcomes in rare disease clinical trials in our latest eBook.
